Forums » News and Announcements

• Aparna Sawant

  

  • 466 posts
   

  June 16, 2021 4:01 AM PDT

  Monoclonal Antibodies (IgMs) are antibodies that are made by identical immune cells, cloned from a single parent cell. They are therefore of constant structure and bind to the same foreign markers (called “antigens&rdquo. The technology behind the generation of monoclonal antibodies was discovered in 1972 by César Milstein and Georges Köhler – scientists at the Roche-funded Basel Institute for Immunology – who were later to win the Nobel Prize. Monoclonal antibodies revolutionized biological research and built the basis for the use of therapeutic antibodies in medicine and for the entire biotechnology industry.
  
  This report contains market size and forecasts of Antibody in South Korea, including the following market information:
  South Korea Antibody Market Revenue, 2015-2020, 2021-2026, ($ millions)
  South Korea Antibody Market Consumption, 2015-2020, 2021-2026, (MT)
  South Korea Antibody Production Capacity, 2015-2020, 2021-2026, (MT)
  Top Five Competitors in South Korea Antibody Market 2019 (%)
  The global Antibody market was valued at 8403.2 million in 2019 and is projected to reach US$ 10240 million by 2026, at a CAGR of 5.1% during the forecast period. While the Antibody market size in South Korea was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.

  
  MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibody manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
  This report also analyses and evaluates the COVID-19 impact on Antibody production and consumption in South Korea
  Total Market by Segment:
  South Korea Antibody Market, By Type, 2015-2020, 2021-2026 ($ millions) & (MT)
  South Korea Antibody Market Segment Percentages, By Type, 2019 (%)
  IgM
  IgG
  IgA
  Other

  For sample report please visit: 

  https://www.statzyreports.com/report/sr240950/antibody-market-in-south-korea

  
  
  South Korea Antibody Market, By Application, 2015-2020, 2021-2026 ($ millions) & (MT)
  South Korea Antibody Market Segment Percentages, By Application, 2019 (%)
  Therapeutic
  Research
  Diagnostic
  
  Competitor Analysis
  The report also provides analysis of leading market participants including:
  Total Antibody Market Competitors Revenues in South Korea, by Players 2015-2020 (Estimated), ($ millions)
  Total Antibody Market Competitors Revenues Share in South Korea, by Players 2019 (%)
  Total South Korea Antibody Market Competitors Sales, by Players 2015-2020 (Estimated), (MT)
  Total South Korea Antibody Market Competitors Sales Market Share by Players 2019 ($ millions)
  Further, the report presents profiles of competitors in the market, including the following:
  Roche
  Johnson & Johnson
  Merck
  Novartis
  AbbVie
  Amgen
  Pfizer
  Bayer
  Lilly
  Bristol-Myers Squibb
  GlaxoSmithKline
  Biogen
  AstraZeneca
  Sanofi
  Alexion Pharmaceuticals

  For sample report please visit: 

  https://www.statzyreports.com/report/sr240950/antibody-market-in-south-korea

  Contact Us:
  Statzy Market Research
  (IN) - +918484035727
  (US) - +1415-871-0483
  Email : info@statzyreports.com
  Email : sales@statzyreports.com
  Website : www.statzyreports.com